Join ISPOR  | Sign up for mailing List  | Follow Us: LinkedIn Twitter Facebook YouTube
Decision-maker Case Study Submission Information
ACCESS TO ONLINE SUBMISSION SYSTEM:
Monday, 23 January 2012
ABSTRACT SUBMISSION DEADLINE:
Thursday, 22 March 2012
ACCEPTANCE NOTIFICATION:
Tuesday, 1 May 2012
ALL PROPOSALS MUST BE SUBMITTED THROUGH ISPOR'S ONLINE ABSTRACT SYSTEM BY 22 MARCH 2012, 11:59 PM (PST).

GENERAL INFORMATION

  • All research abstract submissions, workshop or issue panel proposals, or case studies must be in English.
  • All research abstract, decision-maker case study abstract, workshop and issue panel proposal submissions and presentations must not promote any product or service.
  • Expenses associated with the submission and presentation of an abstract are the responsibility of the presenter.
  • Conference registration is required for all presenters.
  • The presenters of research are required to disclose financial support. Abstract review will NOT be based on this information.
  • The research abstracts, workshops or issue panel proposals, excluding title and author information, should be no longer than 300 words. Decision-maker Case Study abstracts should be no longer than 750 words.
  • The use of tables and graphs in your research abstract submission, workshop or issue panel proposals, or case studies are not allowed.
  • Generic names should be used for technologies (drugs, devices), not trade names.
  • Research that has been published or presented at any national or international meeting prior to this Conference is discouraged.
  • Research presented at a previous ISPOR meeting is not allowed.
  • Multiple abstracts on the same study are discouraged.
CASE STUDY SUBMISSION INFORMATION
  • Case Study abstracts from health care decision makers are designed to describe situations where organizations attempted to integrate cost and outcome information into their processes and procedures for pharmaceuticals, devices, or medical procedures. ISPOR encourages submissions describing successes, works in progress, or failures in this domain.
  • The case study should include issues involved in the process or decision including the usefulness or non-usefulness of the outcomes research information, and recommendations, if appropriate, on the outcomes research information regarding information transparency, completeness of data, format or presentation of information.
  • Decision makers from government and/or private health insurance plans, managed care organizations, integrated delivery systems, pharmacy benefit management organizations, hospitals and clinics are encouraged to submit case studies. The presenting author must be the health care decision-maker for the case study presented.  Co authors can include any individual involved in the case study.

POSSIBLE TOPICS FOR CASE STUDY ABSTRACTS

Topics for case study abstracts may include but are not limited to:

  • Attempts to introduce cost or cost-effectiveness information into formulary decision making processes of Pharmacy and Therapeutics committees.
  • Pay for performance programs that focus on patient oriented outcomes or reducing health care expenditures.
  • Initiatives to measure patient reported outcomes as part of clinical quality improvement initiatives.
  • Purchasing or contracting negotiations with manufacturers that involve cost-effectiveness or outcomes measures as opposed to product prices.

Case Study Abstract Example

 

 

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2014 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.